AAAAAA
Results:
1-16
|
Results: 16
Authors:
Davis, CB
Citation: Cb. Davis, Assessment of the ATHENA code for calculating the void fraction of a lead-bismuth/steam mixture in vertical upflow, NUCL TECH, 133(2), 2001, pp. 187-193
Authors:
Hepburn, TW
Hart, TK
Horton, VL
Sellers, TS
Tobia, LP
Urbanski, JJ
Shi, W
Davis, CB
Citation: Tw. Hepburn et al., Pharmacokinetics and tissue distribution of SB-251353, a novel human CXC chemokine, after intravenous administration to mice, J PHARM EXP, 298(3), 2001, pp. 886-893
Authors:
Scott, MK
Ross, TM
Lee, DHS
Wang, HY
Shank, RP
Wild, KD
Davis, CB
Crooke, JJ
Potocki, AC
Reitz, AB
Citation: Mk. Scott et al., 2,3-dihydro-dithiin and -dithiepine-1,1,4,4-tetroxides: Small molecule non-peptide antagonists of the human galanin hGAL-1 receptor, BIO MED CH, 8(6), 2000, pp. 1383-1391
Authors:
Lee, J
Davis, CB
Rivero, RA
Reitz, AB
Shank, RP
Citation: J. Lee et al., Synthesis and structure-activity relationship of novel pyridyl ethers for the nicotinic acetylcholine receptor, BIOORG MED, 10(10), 2000, pp. 1063-1066
Authors:
Zia-Amirhosseini, P
Harris, RZ
Cowley, HC
Valle, JW
Citerone, DR
Boppana, VK
Scarffe, H
Watson, P
Davis, CB
Citation: P. Zia-amirhosseini et al., Pharmacokinetics of a hematoregulatory peptide (SK&F 107647) in healthy male volunteers and in patients with colorectal or pancreatic adenocarcinoma not amenable to standard therapy, PHARM RES, 17(4), 2000, pp. 385-390
Authors:
Polkinghorne, ST
Davis, CB
McCracken, RT
Citation: St. Polkinghorne et al., Analysis of an advanced test reactor small-break loss-of-coolant accident with an engineered safety feature to automatically trip the primary coolantpumps, NUCL TECH, 132(1), 2000, pp. 167-178
Authors:
Sharma, A
Davis, CB
Tobia, LAP
Kwok, DC
Tucci, MG
Gore, ER
Herzyk, DJ
Hart, TK
Citation: A. Sharma et al., Comparative pharmacodynamics of keliximab and clenoliximab in transgenic mice bearing human CD4, J PHARM EXP, 293(1), 2000, pp. 33-41
Authors:
Benincosa, LJ
Chow, FS
Tobia, LP
Kwok, DC
Davis, CB
Jusko, WJ
Citation: Lj. Benincosa et al., Pharmacokinetics and pharmacodynamics of a humanized monoclonal antibody to factor IX in cynomolgus monkeys, J PHARM EXP, 292(2), 2000, pp. 810-816
Authors:
Wang, HY
Lee, DHS
Davis, CB
Shank, RP
Citation: Hy. Wang et al., Amyloid peptide A beta(1-42) binds selectively and with picomolar affinityto alpha 7 nicotinic acetylcholine receptors, J NEUROCHEM, 75(3), 2000, pp. 1155-1161
Authors:
Brooks, SA
Dontha, N
Davis, CB
Stuart, JK
O'Neill, G
Kuhr, WG
Citation: Sa. Brooks et al., Segregation of micrometer-dimension biosensor elements on a variety of substrate surfaces, ANALYT CHEM, 72(14), 2000, pp. 3253-3259
Authors:
Perera, A
Burleigh, JR
Davis, CB
Citation: A. Perera et al., Movement and retention of propanil N-(3,4-dichlorophenyl)propanamide in a paddy-riverine wetland system in Sri lanka, AGR ECO ENV, 72(3), 1999, pp. 255-263
Authors:
Davis, CB
McNichols, RJ
Citation: Cb. Davis et Rj. Mcnichols, Simultaneous nonparametric prediction limits, TECHNOMET, 41(2), 1999, pp. 89-101
Authors:
Davis, CB
McNichols, RJ
Citation: Cb. Davis et Rj. Mcnichols, Simultaneous nonparametric prediction limits - Response, TECHNOMET, 41(2), 1999, pp. 108-112
Authors:
Zia-Amirhosseini, P
Minthorn, E
Benincosa, LJ
Hart, TK
Hottenstein, CS
Tobia, LAP
Davis, CB
Citation: P. Zia-amirhosseini et al., Pharmacokinetics and pharmacodynamics of SB-240563, a humanized monoclonalantibody directed to human interleukin-5, in monkeys, J PHARM EXP, 291(3), 1999, pp. 1060-1067
Authors:
Mould, DR
Davis, CB
Minthorn, EA
Kwok, DC
Elliott, MJ
Luggen, ME
Totoritis, MC
Citation: Dr. Mould et al., A population pharmacokinetic-pharmacodynamic analysis of single doses of clenoliximab in patients with rheumatoid arthritis, CLIN PHARM, 66(3), 1999, pp. 246-257
Authors:
Davis, CB
Citation: Cb. Davis, Reading the ventriloquist's lips - The performance genre behind the metaphor, TDR, 42(4), 1998, pp. 133-156
Risultati:
1-16
|